一个三基因签名揭示了从NAFLD到HCC的进展中瘤免疫微环境的变化
Lijuan Liu1, Haonan Tang1, Kui Wang1
1Guangxi Medical University Cancer Hospital, Nan Ning, Guangxi Zhuang Autonomous Region, China.
Scientific reports
|December 15, 2023
概括
与肥胖相关的脂肪肝疾病 (NAFLD/NASH) 是肝细胞癌 (HCC) 的一个主要风险因素. 这项研究确定了关键基因 (TEAD4,SOCS2,CIT) 来预测HCC风险,并探索了瘤免疫微环境.
科学领域:
- 在瘤学瘤学.
- 肝病学 肝病学是一种肝病学.
- 遗传学 遗传学 是一个
- 免疫学 免疫学 免疫学
背景情况:
- 肝细胞癌 (HCC) 是癌症死亡的主要原因.
- 非酒精性脂肪性肝病 (NAFLD) 和非酒精性脂肪性肝炎 (NASH) 的增长率是HCC发展的重要风险因素.
- 了解NAFLD/NASH恶性转变的机制对于早期预防和诊断至关重要.
研究的目的:
- 为了确定NAFLD,NASH和HCC之间的共享差异基因.
- 使用已识别的基因开发HCC的预后风险预测模型.
- 研究瘤免疫微环境在NAFLD/NASH相关的HCC中的作用.
主要方法:
- 在NAFLD,NASH和HCC数据集上的差异基因表达分析.
- 使用TCGA,ICGC,GSE116174和GSE54236数据集构建和验证一个三基因 (TEAD4,SOCS2,CIT) 预后模型.
- 评估不同风险群体的免疫细胞透和功能.
- 在HCC细胞系和临床样本中实验验证CIT表达和功能的验证.
主要成果:
- 一个包括TEAD4,SOCS2和CIT的预后模型被开发和验证.
- 在高风险和低风险人群之间观察到免疫状况和功能的显著差异.
- 证实CIT在HCC发育中起作用.
结论:
- 这项研究强调了瘤免疫微环境在NAFLD/NASH向HCC进展中的关键作用.
- 开发的预后模型有助于理解HCC的发病过程,并可能有助于临床决策.
- 对已识别的基因和免疫因子进行进一步的研究可以改善HCC的早期检测和治疗策略.
更多相关视频
07:32Author Spotlight: Investigating Immune Cell Dynamics in the Tumor Microenvironment — Challenges and Innovations in Cancer Prognosis
Published on: April 12, 2024
1.3K
07:47Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies
Published on: September 15, 2023
1.5K
相关概念视频
lncRNA - Long Non-coding RNAs
8.6K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.6K
The Tumor Microenvironment
6.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K
